Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults

被引:36
作者
Kirschner, J
Moll, GH
Fietzek, UM
Heinrich, H
Mall, V
Berweck, S
Heinen, F
Rothenberger, A
机构
[1] Univ Freiburg, Kinderklin, Dept Neuropediat & Muscle Disorders, Freiburg, Germany
[2] Univ Klinikum Gottingen, Dept Child & Adolescent Psychiat, Gottingen, Germany
[3] Christian Albrechts Univ Kiel Klinikum, Dept Neurol, Kiel, Germany
[4] Childrens Hosp, Wedau Kliniken, Duisburg, Germany
关键词
HUMAN MOTOR CORTEX; DEFICIT HYPERACTIVITY DISORDER; EXCITABILITY; ATTENTION; PHARMACOKINETICS; NARCOLEPSY; MECHANISMS; MODULATION; RESPONSES; BRAIN;
D O I
10.1055/s-2003-39049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Transcranial magnetic stimulation was used to investigate the effect of the psychostimulant drug methylphenidate (MPH) on motor cortex excitability in healthy adults (n = 12) in a placebo-controlled, Crossover design study. MPH caused an enhancement of intracortical inhibition as well as intracortical facilitation. Enhancement of both of these TMS parameters was unexpected and suggests that MPH exerts its action on the motor cortex not only through the dopaminergic neurotransmitter system.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 16 条
  • [1] ALDRICH MS, 1994, SLEEP, V17, P598
  • [2] Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD
    Barkley, RA
    [J]. PSYCHOLOGICAL BULLETIN, 1997, 121 (01) : 65 - 94
  • [3] Mechanisms influencing stimulus-response properties of the human corticospinal system
    Boroojerdi, B
    Battaglia, F
    Muellbacher, W
    Cohen, LG
    [J]. CLINICAL NEUROPHYSIOLOGY, 2001, 112 (05) : 931 - 937
  • [4] DIFFERENTIAL MODULATION BY DOPAMINE OF RESPONSES EVOKED BY EXCITATORY AMINO-ACIDS IN HUMAN CORTEX
    CEPEDA, C
    RADISAVLJEVIC, Z
    PEACOCK, W
    LEVINE, MS
    BUCHWALD, NA
    [J]. SYNAPSE, 1992, 11 (04) : 330 - 341
  • [5] PRIMATE MODELS OF MOVEMENT-DISORDERS OF BASAL GANGLIA ORIGIN
    DELONG, MR
    [J]. TRENDS IN NEUROSCIENCES, 1990, 13 (07) : 281 - 285
  • [6] Treatment modalities for narcolepsy
    Fry, JM
    [J]. NEUROLOGY, 1998, 50 (02) : S43 - S48
  • [7] Pharmacokinetics and clinical effectiveness of methylphenidate
    Kimko, HC
    Cross, JT
    Abernethy, DR
    [J]. CLINICAL PHARMACOKINETICS, 1999, 37 (06) : 457 - 470
  • [8] CORTICOCORTICAL INHIBITION IN HUMAN MOTOR CORTEX
    KUJIRAI, T
    CARAMIA, MD
    ROTHWELL, JC
    DAY, BL
    THOMPSON, PD
    FERBERT, A
    WROE, S
    ASSELMAN, P
    MARSDEN, CD
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1993, 471 : 501 - 519
  • [9] Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate
    Moll, GH
    Heinrich, H
    Trott, GE
    Wirth, S
    Rothenberger, A
    [J]. NEUROSCIENCE LETTERS, 2000, 284 (1-2) : 121 - 125
  • [10] Noradrenergic modulation of human cortex excitability by the presynaptic α2-antagonist yohimbine
    Plewnia, C
    Bartels, M
    Cohen, L
    Gerloff, C
    [J]. NEUROSCIENCE LETTERS, 2001, 307 (01) : 41 - 44